Shareholders Approve Reverse Split, Massive Share Increase, and Deeply Discounted Preferred Stock Sale

summarizeSummary

Tianci International shareholders approved a reverse stock split, a substantial increase in authorized common shares, and the sale of deeply discounted preferred stock, signaling significant financial challenges and potential future dilution.

check_boxKey Events

• Reverse Stock Split Approved

  Shareholders authorized the Board of Directors to effect a reverse stock split at a ratio ranging from one-for-two to one-for-one-hundred within one year, without further shareholder approval. This follows the PRE 14A and DEF 14A filings on January 2 and January 13, 2026, respectively, which sought this approval.

• Authorized Shares Massively Increased

  The number of authorized shares of common stock was increased to 2,000,000,000, a substantial increase from the approximately 24.5 million shares outstanding, enabling significant future dilution. This also follows the DEF 14A filing on January 13, 2026.

• Deeply Discounted Preferred Stock Sale Approved

  Shareholders approved the sale of 30,000 shares of Series C Preferred Stock to RQS Capital Limited for an aggregate price of $30,000. Each Series C Preferred share is exchangeable for 100 common shares and carries 100 common share voting rights, effectively selling 3 million common share equivalents at an extremely low price of $0.01 per share, representing substantial dilution at a deep discount to the current market price.

• Director Elections & Auditor Ratification

  The annual meeting also saw the re-election of seven directors and the ratification of Bush & Associates CPA as the independent registered public accounting firm for the fiscal year ending July 31, 2026.

auto_awesomeAnalysis

The approval of these proposals indicates the company is taking drastic measures to address its financial situation and maintain its Nasdaq listing. The authorization for a reverse stock split, with a wide ratio range, suggests efforts to boost the per-share price. The increase in authorized common shares to 2 billion, from approximately 24.5 million outstanding, creates substantial room for future dilution. Most critically, the approval to sell Series C Preferred Stock to RQS Capital Limited for $30,000, where each preferred share is exchangeable for 100 common shares, effectively sells 3 million common share equivalents at an extremely low price of $0.01 per share, representing significant dilution at a deep discount to the current market price. This financing structure points to a company in distress, securing capital under highly unfavorable terms. Investors should be aware of the substantial dilution risk and the implications for shareholder value.